Dexcom DXCM
NASDAQ DXCM
$90.62 +0.74 (+0.83%)
At close: Aug 20, 2026 · 1:10 PM UTC

Dexcom (DXCM) Acquisitions (2021 - 2022)

Dexcom (DXCM) posted quarterly Acquisitions of $700000.0 for Q3 2022, down 97.78% year-over-year from $31.6 million in Q3 2021, and down 78.12% quarter-over-quarter from $3.2 million in Q1 2022.

Dexcom (DXCM) Acquisitions (2021 - 2022) Analysis & Trends

Dexcom (DXCM) has reported Acquisitions for 2 consecutive years, with $700000.0 the latest figure, recorded in Q3 2022.

  • In Q3 2022, Acquisitions fell 97.78% year-over-year to $700000.0; the TTM figure through Jun 2023 stood at $700000.0 (down 97.9% YoY), while the FY2022 annual figure was $3.9 million, down 87.09% from the prior year.
  • Acquisitions retreated to $700000.0 in Q3 2022 per DXCM's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Acquisitions topped out at $31.6 million in Q3 2021 and bottomed at -$1.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn -
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 437.00 Mn
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 406.00 Mn
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn -
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn -
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn -4.00 Mn
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn -3.49 Mn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 16.00 Mn
10 Zimmer Biomet Holdings 19.32 Bn 18.91 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2022 700,000.00
Mar 31, 2022 3.20 Mn
Dec 31, 2021 -1.40 Mn
Sep 30, 2021 31.60 Mn